Utilization of assay performance characteristics to estimate hemoglobin A1c result reliability

Clinical Chemistry

Volumn 60, Issue 8, 2014, Pages 1073-1079

  Woodworth, Alison ^a   Korpi Steiner, Nichole ^b   Miller, James J ^c   Rao, Lokinendi V ^d   Yundt Pacheco, John ^e   Kuchipudi, Lakshmi ^e   Parvin, Curtis A ^e   Rhea, Jeanne M ^f   Molinaro, Ross ^f  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d UMASS MEMORIAL MEDICAL CENTER   (United States)

^e Bio Rad Quality System Division   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; ASSAY ANALYZER; BIOCHEMICAL EQUIPMENT; CLINICAL PROTOCOL; HEMOGLOBINOMETER; PROTEIN DETERMINATION; QUALITY CONTROL;

HEMOGLOBIN A, GLYCOSYLATED; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 84905278069     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.220772     Document Type: Article

References (13)

1. Midyett R. "Empty QC": when QC is out of control. MLO Med Lab Obs 2012;44:22, 24, 26.
2. Williams M. Risk assessment and quality control: be ready for the new guidance. MLO Med Lab Obs 2012;44:18,20-1.
3. UnitedHealth Center for Health Reform and Modernization. The United States of Diabetes: challenges and opportunities in the decade ahead. http://www.unitedhealthgroup.com/~/media/UHG/PDF/2010/UNH-Working-Paper-5-Fact- Sheet.ashx (Accessed May 2014).
4. American Diabetes Association. Standards of medical care in diabetes - 2013. Diabetes Care 2013;36 Suppl 1:S11-66.
5. Little RR, Rohlfing CL, Sacks DB; National Glycohemoglobin Standardization Program (NGSP) Steering Committee. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 2011;57:205-14.
6. Parvin CA. Assessing the impact of the frequency of quality control testing on the quality of reported patient results. Clin Chem 2008;54:2049-54. (Pubitemid 352774039)
7. Schoenmakers CH, Naus AJ, Vermeer HJ, van Loon D, Steen G. Practical application of Sigma Metrics QC procedures in clinical chemistry. Clin Chem Lab Med 2011;49:1837-43.
8. CLSI. Laboratory quality control based on risk management: approved guideline. Wayne (PA): CLSI; 2011. CLSI document EP23-A.
9. Westgard JO. Perspectives on quality control, risk management, and analytical quality management. Clin Lab Med 2013;33:1-14.
10. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011;57:e1-47.
11. Kuchipudi L, Yundt-Pacheco J, Parvin CA. Computing a patient-based sigma metric. Clin Chem 2010;56:A-107.
12. Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem 2010;56:44-52.
13. Westgard JO. Best practices for "Westgard Rules." http://www.westgard.com/lesson74.htm (Accessed October 2013).